Victory Square and future catalystsRapid 5-15min Antibody test 93.3% sensitivity and 98.7% specificity based on real human trials. Unique low cost2-in-1 test for active AND previous infection FDA EUA Approval Brazil ANVISA Approval EU CE Approval Only test approved through Sao Paolo Government Ideiagov program Increased Brazil manufacturing capacity of 5MM bringing total to 6-7MM / month EPS of .7, portfolio of 20+ companies that are reaching maturity. Catalysts: Health Canada Approval India Approval Full FDA Approval NDAs becoming definitive agreements Preorders becoming definitive agreements Increased manufacturing capacity Acquisition of accredited productions labs 360 Healthcare platform to compliment test